Fermion Biosystems

Executive Summary

Fermion Biosystems is a San Francisco-based consulting and contracting firm specializing in accelerating early-stage biotechnology and bioelectronics R&D. Founded in 2019, the company offers integrated circuit design, electronics, software, and microfabrication services to enable rapid proof-of-concept studies for novel bioelectronics systems. By bridging the gap between academic research and commercial viability, Fermion helps startups and laboratories reduce development timelines and costs. Despite its niche expertise, the company operates as a service provider with no disclosed funding rounds or pipeline products, limiting its visibility in the investment community. Its success hinges on securing high-value contracts and repeat engagements from biotech innovators.

Upcoming Catalysts (preview)

• Q3 2026Major Contract Win with Top-Tier Biotech Startup30% success
• Q4 2026Expansion of Service Offerings into Neural Interfaces20% success
• Q2 2027Strategic Partnership with a Microfabrication Foundry15% success